Skip to main content
Premium Trial:

Request an Annual Quote

MDVIP Physician Network to Offer Exact Sciences' ColoGuard

NEW YORK (GenomeWeb) – Exact Sciences today announced that physicians network MDVIP will make Exact's ColoGuard colorectal cancer screening test available to its affiliated nationwide network of more than 750 primary care physicians.

In a statement, MDVIP Chief Medical Officer Andrea Klemes said that adoption of ColoGuard "will allow our patients who are 50 years and older and at average risk for colorectal cancer an easy-to-use screening test which they can do in the privacy of their own home."

In August, Exact Sciences simultaneously received US Food and Drug Administration approval for Cologuard and a proposed National Coverage Determination from The Centers for Medicare & Medicaid Services.

The test is the first FDA-approved and Medicare-reimbursed non-invasive screening test for colorectal cancer that analyzes both stool-based DNA and blood biomarkers to detect cancer and precancer. CMS's final NCD this month deemed Cologuard to have sufficient evidence for coverage as a screening test for asymptomatic, average-risk beneficiaries aged 50 to 85 years, and set reimbursement at $502.

Prior to the finalized NCD, Exact Sciences announced that Group Health Cooperative would be the first health plan in Wisconsin to offer its patients Cologuard. In August, Mayo Clinic signed on as the first health system to adopt the test.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.